We are live on ! Find out more
FRM

Fox Run Management Portfolio holdings

AUM $572M
1-Year Est. Return 24.16%
This Fund
S&P 500
This Quarter Est. Return
+9.22%
1 Year Est. Return
+24.16%
3 Year Est. Return
+44.85%
5 Year Est. Return
+32.84%
10 Year Est. Return
+244.98%
AUM
$124M
AUM Growth
+$14.4M
Cap. Flow
+$8.49M
Cap. Flow %
6.84%
Top 10 Hldgs %
8.4%
Holding
601
New
263
Increased
50
Reduced
50
Closed
238

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.25M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$1.25M
3
HAE icon
Haemonetics
HAE
+$779K
4
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$759K
5
GDDY icon
GoDaddy
GDDY
+$694K

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$858K
2
DXC icon
DXC Technology
DXC
+$821K
3
WST icon
West Pharmaceutical
WST
+$728K
4
LUV icon
Southwest Airlines
LUV
+$717K
5
HWM icon
Howmet Aerospace
HWM
+$650K

Sector Composition

Rank Sector Weight
1 Technology 15.52%
2 Industrials 13.79%
3 Consumer Discretionary 12.99%
4 Healthcare 11.5%
5 Financials 9.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MD icon
176
Pediatrix Medical
MD
$2.16B
$316K 0.25%
+11,379
New +$285K
ENR icon
177
Energizer
ENR
$1.44B
$315K 0.25%
6,280
+1,443
+30% +$66.4K
GES
178
DELISTED
Guess Inc
GES
$315K 0.25%
14,074
+2,005
+17% +$37.4K
TGT icon
179
Target
TGT
$62.1B
$314K 0.25%
2,447
-3,429
-58% -$402K
KEYS icon
180
Keysight
KEYS
$54.5B
$313K 0.25%
3,052
+876
+40% +$89.7K
FISV
181
Fiserv Inc
FISV
$27.2B
$312K 0.25%
2,694
-294
-10% -$32.5K
GWPH
182
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$312K 0.25%
+2,987
New +$335K
JBL icon
183
Jabil
JBL
$32.8B
$311K 0.25%
+7,520
New +$289K
PRO
184
DELISTED
PROS Holdings
PRO
$310K 0.25%
+5,166
New +$298K
THS
185
DELISTED
Treehouse Foods
THS
$310K 0.25%
+6,393
New +$327K
FR icon
186
First Industrial Realty Trust
FR
$8.88B
$309K 0.25%
+7,453
New +$307K
CSL icon
187
Carlisle Companies
CSL
$13.6B
$307K 0.25%
+1,897
New +$292K
HII icon
188
Huntington Ingalls Industries
HII
$11.3B
$306K 0.25%
+1,219
New +$289K
UFS
189
DELISTED
DOMTAR CORPORATION (New)
UFS
$306K 0.25%
+7,991
New +$296K
AMGN icon
190
Amgen
AMGN
$203B
$305K 0.25%
+1,265
New +$279K
IART icon
191
Integra LifeSciences
IART
$1.54B
$305K 0.25%
+5,230
New +$311K
PLNT icon
192
Planet Fitness
PLNT
$4.23B
$305K 0.25%
+4,083
New +$275K
TER icon
193
Teradyne
TER
$54.8B
$305K 0.25%
+4,475
New +$284K
EV
194
DELISTED
Eaton Vance Corp.
EV
$305K 0.25%
6,540
+1,229
+23% +$56.8K
BCE icon
195
BCE
BCE
$19.9B
$303K 0.24%
+6,533
New +$313K
TMO icon
196
Thermo Fisher Scientific
TMO
$211B
$303K 0.24%
+933
New +$283K
BL icon
197
BlackLine
BL
$1.69B
$301K 0.24%
+5,835
New +$291K
VSAT icon
198
Viasat
VSAT
$9.79B
$301K 0.24%
+4,107
New +$294K
CXW icon
199
CoreCivic
CXW
$3.1B
$300K 0.24%
+17,249
New +$273K
MMS icon
200
Maximus
MMS
$3.14B
$299K 0.24%
+4,018
New +$302K
6 7
8
9 10

Similar funds

MAM
McLean Asset Management Tysons, Virginia $572M AUM 22% 1-Year Est. Return
NA
Nordwand Advisors Radnor, Pennsylvania $572M AUM 23.09% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $572M AUM 67.49% 1-Year Est. Return
MW
Marble Wealth Montgomery, Alabama $571M AUM
BSG
Black Swift Group Boulder, Colorado $571M AUM 36.77% 1-Year Est. Return
RI
RPTC Inc Jackson, Wyoming $571M AUM 19.82% 1-Year Est. Return
XI
XXEC Inc Tulsa, Oklahoma $571M AUM 1.42% 1-Year Est. Return
TWA
Tulsa Wealth Advisors Tulsa, Oklahoma $570M AUM

Fox Run Management's Q4 2019 Portfolio in Review

As of Q4 2019, Fox Run Management held 601 positions worth $124M, up 13% from $110M the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.

Fox Run Management deployed $8.49M of net new capital in Q4 2019, opening 263 new positions and adding to 50 existing holdings. Its largest new stake was Haemonetics: 6,441 shares worth $740K.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Generac Holdings, an estimated $629K trimmed.

  • Fox Run Management's largest Q4 2019 buy was Haemonetics: 6,441 shares worth $740K.
  • Fox Run Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $1.25M increase.
  • Fox Run Management's biggest Q4 2019 reduction was Generac Holdings, cutting an estimated $629K.
  • Fox Run Management fully exited Pfizer in Q4 2019, selling an estimated $858K.
  • Fox Run Management's ten largest holdings make up 8.4% of its $124M portfolio in Q4 2019.
  • Fox Run Management opened 263 new positions and closed 238 in Q4 2019.
  • Fox Run Management's portfolio value rose 13% quarter-over-quarter to $124M.

Based on Fox Run Management's 13F filing for Q4 2019, filed 14 Feb 2020.